PPN20: Estimated Resource Use and Cost of Mitoxantrone vs Placebo in Patients with Progressive-Relapsing and Secondary-Progressive Multiple Sclerosis: Results from the MIMS Trial : International Society for Pharmacoeconomics and Outcomes Research
In: VALUE IN HEALTH 4(NO 2):160-160; Jg. 4 (2001) NO 2, S. 160-160
Online
Konferenz
Zugriff:
Titel: |
PPN20: Estimated Resource Use and Cost of Mitoxantrone vs Placebo in Patients with Progressive-Relapsing and Secondary-Progressive Multiple Sclerosis: Results from the MIMS Trial : International Society for Pharmacoeconomics and Outcomes Research
|
---|---|
Autor/in / Beteiligte Person: | Durgin, T. L. ; Wanke, L. A. ; Goodkin, D. ; Ghalie, R. |
Link: | |
Quelle: | VALUE IN HEALTH 4(NO 2):160-160; Jg. 4 (2001) NO 2, S. 160-160 |
Veröffentlichung: | 2001 |
Medientyp: | Konferenz |
ISSN: | 1098-3015 (print) |
Sonstiges: |
|